Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John A Hassell

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
BMC Research Notes|April 2, 2011
E2F1 and KIAA0191 expression predicts breast cancer patient survivalRobin M Hallett, John A Hassell
Plos One|July 31, 2014
Identification of a novel luminal molecular subtype of breast cancerAnna Dvorkin-Gheva, John A Hassell
DNA and Cell Biology|May 2, 2008
The transactivation function of the Pea3 subfamily Ets transcription factors is regulated by sumoylationB Bonnie Bojović, John A Hassell
Plos One|October 25, 2011
Hormone receptor and ERBB2 status in gene expression profiles of human breast tumor samplesAnna Dvorkin-Gheva, John A Hassell
BMC Cancer|November 26, 2014
Estrogen independent gene expression defines clinically relevant subgroups of estrogen receptor positive breast cancerRobin M Hallett, John A Hassell
BMC Medical Genomics|May 15, 2012
A target based approach identifies genomic predictors of breast cancer patient response to chemotherapyRobin M Hallett, Gregory Pond, John A Hassell
BMC Research Notes|August 20, 2014
A program to identify prognostic and predictive gene signaturesSam D Chorlton, Robin M Hallett, John A Hassell
FEBS Letters|February 28, 2004
Activation of the WT1 tumor suppressor gene promoter by Pea3Maria Teresa Discenza, Darryl Vaz, John A Hassell, et al.
Developmental Cell|April 24, 2009
FGF-regulated Etv genes are essential for repressing Shh expression in mouse limb budsZhen Zhang, Jamie M Verheyden, John A Hassell, et al.
Scientific Reports|February 23, 2012
A gene signature for predicting outcome in patients with basal-like breast cancerRobin M Hallett, Anna Dvorkin-Gheva, Anita Bane, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
BMC Research Notes|April 2, 2011
E2F1 and KIAA0191 expression predicts breast cancer patient survivalRobin M Hallett, John A Hassell
Plos One|July 31, 2014
Identification of a novel luminal molecular subtype of breast cancerAnna Dvorkin-Gheva, John A Hassell
DNA and Cell Biology|May 2, 2008
The transactivation function of the Pea3 subfamily Ets transcription factors is regulated by sumoylationB Bonnie Bojović, John A Hassell
Plos One|October 25, 2011
Hormone receptor and ERBB2 status in gene expression profiles of human breast tumor samplesAnna Dvorkin-Gheva, John A Hassell
BMC Cancer|November 26, 2014
Estrogen independent gene expression defines clinically relevant subgroups of estrogen receptor positive breast cancerRobin M Hallett, John A Hassell
BMC Medical Genomics|May 15, 2012
A target based approach identifies genomic predictors of breast cancer patient response to chemotherapyRobin M Hallett, Gregory Pond, John A Hassell
BMC Research Notes|August 20, 2014
A program to identify prognostic and predictive gene signaturesSam D Chorlton, Robin M Hallett, John A Hassell
FEBS Letters|February 28, 2004
Activation of the WT1 tumor suppressor gene promoter by Pea3Maria Teresa Discenza, Darryl Vaz, John A Hassell, et al.
Developmental Cell|April 24, 2009
FGF-regulated Etv genes are essential for repressing Shh expression in mouse limb budsZhen Zhang, Jamie M Verheyden, John A Hassell, et al.
Scientific Reports|February 23, 2012
A gene signature for predicting outcome in patients with basal-like breast cancerRobin M Hallett, Anna Dvorkin-Gheva, Anita Bane, et al.
Pageof 5